Beyond Approval: The Hidden Risk in Biotech Stocks
The legendary fund manager Peter Lynch advised investors to “invest in what you know.” It’s a principle that holds true—if you work in an industry and understand its inner workings, that knowledge can help you identify opportunities—or at least recognize risks that others might overlook. When
How Public Speaking Taught Me to Stop Explaining and Start Connecting
A few months ago, I joined an English-speaking club in Munich – about an hour’s drive from where I live, just across the border. I’ve always loved stories and the ideas they carry. But despite that fascination, I found it difficult to speak
Mind the Gap: Bridging Drug and Device Thinking
A few months ago, I stepped into a new role – shifting from biologics development to device development within the same company. It’s been an exciting change and an opportunity to expand my perspective on pharmaceutical development. While bot
Tariff Shocks and Portfolio Lessons: Navigating Uncertainty in a Volatile Market
In early April, amid rising geopolitical tensions and economic uncertainty, I made the decision to reduce my exposure to certain consumer discretionary and tech stocks in my portfolio – one of them being Alphabet, the parent company of Google.
Impressions from Venice Biennale and the Rise of the Immersive Art Experience
Art has the power to shift our perspectives and occasionally to immerse us so deeply that we forget our surroundings entirely. My recent trip to the Venice Biennale was a reminder of this power – a journey not just across borders but into realm
The short story of my website and personal brand
After experimenting with social media platforms, I found their formats a bit limiting. I wanted a space that offered more creative freedom – a place to fully express and unify my diverse roles and interests in science, art and design. This led
